These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 14793863)

  • 41. [Adrenal hirsutism (3-beta-hydroxysteroid dehydrogenase deficiency). Studies using a chromatographic separation of the urinary 17-ketosteroid fraction. 2. Dehydroepiandrosterone-forming adrenal hyperplasia and constitutional hirsutism].
    Göbel P
    Endokrinologie; 1967; 52(3):168-201. PubMed ID: 4297835
    [No Abstract]   [Full Text] [Related]  

  • 42. Urinary excretion of 17-ketosteroids after the single injection of testosterone cyclopentylpropionate and testosterone propionate.
    HURXTHAL LM; MACMILLAN
    Lahey Clin Bull; 1953 Apr; 8(4):101-4. PubMed ID: 13053723
    [No Abstract]   [Full Text] [Related]  

  • 43. Isolation of steroids from the urine of patients with adrenal cortical tumors and adrenal cortical hyperplasia; a new 17-ketosteroid, androstane-3 (alpha) 11-diol-17-one.
    MASON HL; KEPIER EJ
    J Biol Chem; 1945; 161():235-57. PubMed ID: 21005731
    [No Abstract]   [Full Text] [Related]  

  • 44. Urinary steroid excretion before and after dexamethasone administration and steroid content of adrenal tissue and venous blood in virilizing adrenal tumors.
    Mahesh VB; Greenblatt RB; Coniff RF
    Am J Obstet Gynecol; 1968 Apr; 100(8):1043-54. PubMed ID: 5643182
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent studies on adrenal hyperplasia.
    JAILER JW
    Trans N Y Acad Sci; 1951 May; 13(7):262-3. PubMed ID: 14855608
    [No Abstract]   [Full Text] [Related]  

  • 46. [RESULTS OF PROLONGED CORTISONE TREATMENT IN PATIENTS WITH CONGENITAL ADRENOGENITAL SYNDROME].
    RIJDTAJ TE; TERPSTRA J; QUERIDO A
    Ned Tijdschr Geneeskd; 1963 Nov; 107():2091-6. PubMed ID: 14097757
    [No Abstract]   [Full Text] [Related]  

  • 47. "GLOBUS HYSTERICUS". EXCRETION OF 17-KETOSTEROIDS AND KETOGENIC HORMONES. TREATMENT WITH CORTICAL HORMONES.
    KIVIRANTA UK; PESONEN S
    Pract Otorhinolaryngol (Basel); 1964; 26():178-82. PubMed ID: 14155756
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparison of androgens determined biologically and 17-ketosteroids determined chemically in urine (normal and abnormal).
    ZARROW MX; MUNSON PL; SALTER WT
    J Clin Endocrinol Metab; 1950 Jul; 10(7):692-702. PubMed ID: 15436555
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: an attempt to explain and correct its disordered hormonal pattern.
    BARTTER FC; ALBRIGHT F; FORBES AP; LEAF A; DEMPSEY E; CARROLL E
    J Clin Invest; 1951 Mar; 30(3):237-51. PubMed ID: 14824274
    [No Abstract]   [Full Text] [Related]  

  • 50. Renal and adrenal mechanisms of salt conservation: the excretion of urinary formaldehydogenic steroids and 17-ketosteroids during salt deprivation and desoxycorticosterone administration.
    DAUGHADAY WH; MacBRYDE CM
    J Clin Invest; 1950 May; 29(5):591-601. PubMed ID: 15415463
    [No Abstract]   [Full Text] [Related]  

  • 51. [Corticoid and 17-ketosteroid excretion in normal and sick persons].
    STAUDINGER H
    Dtsch Med J; 1953 May; 4(9-10-11-12):293-4. PubMed ID: 13083376
    [No Abstract]   [Full Text] [Related]  

  • 52. Further studies on the treatment of congenital adrenal hyperplasia with cortisone. III. The control of hypertension with cortisone, with a discussion of variations in the type of congenital adrenal hyperplasia and report of a case with probable defect of carbohydrate-regulating hormones.
    WILKINS L; CRIGLER JF; SILVERMAN SH; GARDNER LI; MIGEON CJ
    J Clin Endocrinol Metab; 1952 Aug; 12(8):1015-30. PubMed ID: 14946250
    [No Abstract]   [Full Text] [Related]  

  • 53. [Metabolism of adrenal cortical steroids; clinical observations on the destruction of cortisone and compound F to 17-ketosteroids].
    LABHART A; JENKINS D; FORSHAM P
    Schweiz Med Wochenschr; 1952 Aug; 82(35):877-80. PubMed ID: 12994809
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of convulsive therapy on the excretion of cortins and ketosteroids.
    ASHBY WR
    J Ment Sci; 1949 Apr; 95(399):275-324. PubMed ID: 18145169
    [No Abstract]   [Full Text] [Related]  

  • 55. Chemical transformations of steroids by adrenal perfusion. V. Blood incubations and perfusions with cortisone.
    MEYER AS
    J Biol Chem; 1953 Jul; 203(1):469-87. PubMed ID: 13069530
    [No Abstract]   [Full Text] [Related]  

  • 56. 17-ketosteroids and adrenal tumors.
    JOHNSON HT
    Univ Hosp Bull; 1946 Mar; 12():21-3. PubMed ID: 21016688
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
    Keenan BS; McNeel R; Barrett GN; Holcombe JH; Kirkland RT; Clayton GW
    J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
    [No Abstract]   [Full Text] [Related]  

  • 58. [ROLE OF THE ADRENALS IN FIBRO-SCLEROTIC DEGENERATION OF THE OVARY].
    BARON J
    Ginekol Pol; 1964; 35():197-204. PubMed ID: 14175928
    [No Abstract]   [Full Text] [Related]  

  • 59. The excretion of 17-ketosteroids by normal young men.
    VON MILLER EO; MICKELSEN O; KEYS A
    Fed Proc; 1947; 6(1 Pt 2):279. PubMed ID: 20247609
    [No Abstract]   [Full Text] [Related]  

  • 60. Metabolic studies with a steroid isolated from the urine of patients with "salt-losing" congenital adrenal hyperplasia.
    COPPAGE WS; LIDDLE GW
    J Clin Endocrinol Metab; 1960 May; 20():729-34. PubMed ID: 13811860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.